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ABSTRACT 
This study was designed to investigate whether the ingestion 
of ibuprofen prior to or after a 30-min bout of downhill 
(-10%) treadmill running would result in reduced sensation 
of soreness. A secondary purpose was to investigate whether 
ibuprofen would augment the diminished muscle performance 
following downhill running. Subject consisted of 21 males 
(age= 20.3 ± 1.7 years; weight= 77.4 ± 7.8 kg). Each 
subject was randomly assigned to either a control group, a 
prophylactic group which received 600 mg of ibuprofen 1 hour 
prior to the 30-min treadmill run and (200 mg every 3 hr 
postexercise up to 24 hours), or a therapeutic group which 
ingested 600 mg of ibuprofen at 24-hours postexercise and 
(200 mg every 3 hr till 48-hr postexercise). Multivariate 
ANOVA with a repeated measure revealed no significant 
difference in muscle soreness measures at preexercise, 0-hr, 
24-hr, and 48-hr postexercise between the control, 
prophylactic, or therapeutic groups. Also, there were no 
differences between groups for vertical jump, fatigue index, 
maximal anaerobic power, or work capacity at any of the 
post-exercise testing times. Based on these results, the 
effectiveness of ibuprofen in regressing exercise-induced 
soreness or diminished muscle performance is doubtful. 
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CHAPTER I 
INTRODUCTION 
Soft tissue injuries, like all other tissue injuries, 
have plagued physical performance since early human time. 
The concept of muscle soreness after strenuous activity is a 
universal problem that confronts athletes and other 
occupational personnel alike. Sports participants are 
perhaps the worst victims since the problem has its highest 
incidence in sports participation (Garrett, 1990). Because 
of its inhibitory effects on performance, exercise 
physiologists, athletic coaches, clinicians, trainers, and 
athletes have attempted to find antidotes. 
Exercise-generated pain presents itself in two basic 
forms namely, temporary soreness and residual soreness. 
Temporary soreness occurs in the course of exercise and 
terminates as activity stops (Friden, 1984). In residual 
soreness, the pain is not felt until approximately 8 hours 
after activity and peaks.at 24 to 48-hours postexercise 
(Abraham, 1977). Because of the time lapse between 
termination of activity and its occurrence, residual 
soreness has been dubbed "delayed-onset muscle soreness" 
(DOMS) (Abraham, 1977). Postexercise soreness is the 
symptomatic manifestation of an injury caused to a muscle 
tissue (Friden, 1984). It is the aftermath of strenuous 
activity and characteristic of people who routinely do not 
perform such activity (Friden, 1984). Additionally, 
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activities that are intensive and extend over a long 
duration are also capable of inflicting severe injury 
{Armstrong, 1984; Newham, 1988). About 3 to 4 hours after a 
damage-inducing exercise, a chain of inflammatory events 
involving autogenic destructive processes are believed to 
commence in the myofiber {Almekinders & Gilbert, 1986). 
Phagocytic blood-borne mononuclear cells begin to invade the 
damaged site, and by Days 1 and 2 after exercise, the 
inflammatory reaction becomes more pronounced (Armstrong, 
1990). Other important changes may also occur during the 
pre-invasion period (Armstrong, 1990) however, there is 
still much to be understood (Garrett, 1990). 
Promoting the inflammatory process are identifiable 
mediators such as kinin, histamine, and prostaglandins 
(Weissmann, 1982). Free oxygen radicals have also been 
noted as important mediators in the inflammatory process 
(Armstrong, 1990; Brune, 1982). Even though several 
mediators are present, considering the critical role of the 
cyclooxegenase pathway in the inflammatory reaction, the 
resultant prostaglandins may be a primary intermediate in 
the inflammatory process (Onyanaugui, 1978). 
Inflammation, per se, might not be directly related to 
DOMS however, prostaglandins, a mediator of inflammation, 
has been shown to be a contributor to DOMS (Ferreira, 1972; 
Weissmann, 1982). No specific factor has been identified as 
the primary cause of DOMS but potential physical and 
chemical factors that have.been investigated are rupture to 
muscle and connective tissues (Hough, 1902), tonic spasm 
(deVries, 1966), and edema (Bobbert, Hollander, & Huijing, 
1986; Brendstrup, 1962; Friden, 1984). The period of DQ~S 
is accompanied with a drastic muscle weakness that leads to 
diminished muscle performance (Newham, Jones, & Clarkson, 
1987). Presumably, subjects in pain have little voluntary 
will to activate the sore muscle which eventually causes 
decrements in muscle performance. 
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In spite of the concurrence of DOMS and diminished 
muscle performance, biochemical markers of muscle damage 
such as serum creatine kinase and lactate dehydrogenase do 
not seem to have the same time course as DOMS. This 
suggests that DOMS may not be responsible for the reduced 
functional ability of the injured muscle. Studies have 
indicated that whereas DOMS peaks at 24 to 48-hr 
postexercise, diminished muscle performance persists for 
over 7 days postexercise. Results of studies by Herring 
(1990) and Newham et al. (1987) indicated that at the time 
of diminished DOMS, functional deficits in sore muscles 
existed. The failure of traumatized muscle to exert maximal 
force has been viewed as the result of disorganized muscle 
structure (Newham, McPhail, Mills, & Edwards, 1983). 
Diminished muscle performance that follows the injury 
process has also been attributed to an overextended resting 
length of muscle fibers (Friden, 1984). 
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The negative impact that mechanical and inflammatory 
injuries inflict on subjects have raised concerns in the 
area of human performance. To counteract the ensuing pain 
and diminished muscle performance, traditional and modern 
preventive and curative modalities have evolved (VanHelder, 
1992). Identifiable classical clinical approaches are heat 
therapy; hydrocollator packs and hot immersion; electrical 
or ultrasonic devices; cold compress and gallenium arsenide 
laser. Some studies have also investigated such alleviative 
approaches as exercise (Appell, Soares, & Duarte, 1992; 
iontophoresis (Hasson, Wibble, Reich, Barnes, & Williams, 
1992), and trolamine salicylate (Ciccone, Leggin, & 
Callamaro, 1991). Another modality that has frequently been 
prescribed in recent times is designated as nonsteroidal 
anti-inflammatory drugs (NSAIDs) which include ibuprofen, 
aspirin, and naproxen as will as diclofenac, piroxicam, 
flurprofen, etodolac, diflunisal, oxaprozin, nabumetone, 
azapropazone, fenoprofen, fenbufen, tolmetin, and sulindac 
(McCormack & Brune, 1991). 
The mechanism by which ibuprofen exerts its effect on 
DOMS is still unknown however, three mechanistic modes have 
been proposed namely: (a) analgesia, the shielding of pain 
nerve endings from pain stimuli; (b) anti-nociception, 
chemically blocking muscle excitation in injured muscles; 
and (c) anti-inflammation which involves the blocking of 
cyclooxygenase enzyme which catalyzes the biotransformation 
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of arachidonic acid. Although not universally accepted, 
current thought is that NSAIDs inhibit the synthesis of 
prostaglandins to achieve the analgesic efficacy (Brune et 
al., 1991). McCormack and Brune (1991) have suggested that 
the anti-nociceptive action of NSAIDs could be tied to the 
inhibition of accumulation of prostaglandins and other 
mediators of inflammation. They further argue that the two 
modes of action, analgesia and nociception differ only in 
terminology, but that the chemical processes are basically 
the same. 
Studies that attempt to establish a link between anti-
inflammation and analgesia of NSAIDs have suggested that the 
two mechanisms are inseparable (Ciccone et al., 1991; Hasson 
et al., 1993). Some NSAIDs are also believed to be 
scavengers of the hydroxyl radical (OH-) (Famaey, 1982). 
The scavenging action hastens the transformation of PGG2 
(inflammatory) to PGH2 (less inflammatory) (Onyanaugui, 
1978). There seems to be a clear association among DOMS, 
diminished muscle performance and muscle damage. The damage 
itself can be attributed to mechanical and biochemical 
processes. Using NSAIDs may thus provide reliable 
intervention to DOMS through such mechanistic modes as 
analgesia, antinociception, and anti-inflammation. 
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Statement of the Problem 
The purpose of this study was to investigate the 
effects of ibuprofen ingested either prophylactically or 
therapeutically on delayed-onset muscle soreness and on 
muscle performance following an eccentric-biased running 
bout. 
Significance of the Study 
Previous studies have investigated the effectiveness of 
ibuprofen in reducing DOMS and diminished muscle performance 
but produced conflicting results. Most studies have focused 
on subjective assessment of DOMS to evaluate the efficacy of 
drugs disregarding the deleterious effects of the injury on 
muscular performance. Due to the inconclusiveness of such 
investigations the present study is warranted. 
Research Hypotheses 
The research hypotheses are as follows: 
1. Ibuprofen would diminish DOMS. 
2. Ibuprofen would help restore muscle performance 
more quickly than without. 
3. Prophylactic treatment with ibuprofen would be more 
effective than therapeutic in reducing DOMS and restoring 
muscular performance. 
Assumptions 
The following assumptions were made: 
1. Subjects exerted maximal effort on the cycle 
ergometer and in the vertical jump test. 
2. Subjects abstained from ingesting NSAIDs or 
additional dosages of ibuprofen or other NSAIDs before and 
after the exercise treatment or employing any intervention 
mode to alleviate soreness. 
3. Motivation was equally high in all subjects. 
4. Subjects honestly indicated their true extent of 
soreness perception on the analogue scale. 
5. Instruments and tests used in the study were 
accurate, reliable, and valid. 
6. Pre-testing did not influence post-test scores. 
7. There was consistency.and reliability in the 
soreness measuring scale, the Wingate and vertical jump 
tests. 
Delimitation of the Study 
This study was delimited to the following: 
1. Twenty-one volunteer male students of the 
University of Northern Iowa. 
2. Students who were not participating in any 
intercollegiate sport at the time of the study. 
3. Students between 18 and 33 years of age. 
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4. Healthy individuals (subjects who 3 months prior to 
the study, had not been referred to a physician for any 
muscle injury treatment). 
5. Running on a Quinton 18-60 or a Marquette 2000 T 
motor-driven treadmill in the Human Performance Laboratory 
of the University of Northern Iowa. 
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6. The visual analogue scale used to measure soreness. 
7. The vertical jump and Wingate cycle ergometer 
tests. 
Limitations of the Study 
The following were limitations of the study: 
1. The inability to ensure equal efficacy of the drug 
in all subjects based on varying individual body composition 
and metabolism. 
2. The possibility that subjects may take extra 
dosages of ibuprofen or other NSAIDs. 
3. The uncertainty of honesty or otherwise with which 
subjects disclosed muscle soreness. 
4. The validity and reliability of the testing 
instrument, soreness measurement scale, vertical jump, and 
the Wingate tests. 
Definition of Terms 
1. Prophylactic--the administration of ibuprofen 
before activity. 
2. Therapeutic--the ingestion of ibuprofen 24 hours 
after exercise when soreness begins to reach its peak. 
3. Concentric work--movement in which the muscle 
shortens as it produces force. 
4. Eccentric work--movement in which the muscle 
lengthens as it produces force. 
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7. Antioxidants--substances that help reduce the 
degree of oxygen stress either by forming a lesser active 
radical or inhibiting the reaction. 
8. Nociceptor--a drug that has the potential to shield 
pain receptors. 
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CHAPTER II 
REVIEW OF LITERATURE 
To date, the use of ibuprofen and other pharmacological 
modalities as an antidote to exercise-induced muscular 
soreness has not exhaustively addressed the issue of dosage, 
timing, efficacy in performance restoration, and, most 
importantly, its mode of action. The present study was 
therefore designed to investigate whether the oral ingestion 
of ibuprofen before or after treadmill running would reduce 
pain sensation and more quickly restore muscular 
performance. 
Of the soft tissues injuries associated with sports, 
overload injuries to muscle fibers seem to be the most 
prevalent (Glick, 1980; Ryan, 1969). Victims to such damage 
show such symptomatic signs as pain (Newham, 1988), 
swelling, anatomical deformity, and athletic dysfunction 
(Kibler, 1990; Newham et al., 1987). The cost of muscle 
damage to athletes is enormous and in instances of 
relatively high performance, the cost is expressed in terms 
of high energy expenditure leading to further injuries 
(Kibler, 1990). 
Muscle soreness and occasional diminished muscular 
performance that follow tissue damage are attributable 
primarily to mechanical damage and secondly, to inflammatory 
responses as part of biochemical reactions to the initial 
fiber damage (Almekinders & Gilbert 1986). 
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Muscle Damage 
There is very little clarity about the mechanism that 
leads to DOMS. Ebbeling and Clarkson (1989) however, 
suggest that mechanical and biochemical factors as discussed 
below, could be causative. 
Mechanical Disruption of Cells 
Mechanical stress on muscle fiber is believed to be 
very instrumental in generating structural disruptions which 
later subjects the muscle to further damage through 
biochemical reactions. Arguments in favor of mechanical 
processes as potential cause of muscle damage has been 
investigated and is tied to eccentric motion. In a study 
by Mccully and Faulkner (1985), eccentric motion resulted in 
greater injury to muscle fibers than did isometric or 
concentric activities. Muscles of female albino mice were 
stimulated through isometric contraction and lengthening 
activity. Tissue preparations following the eccentric 
protocol revealed greater damage to the fibers. 
Almekinders (1993) further suggested that during long 
distance running, each running cycle involves a shortening 
and lengthening process of the muscle. The singular impact 
of this process is less than enough to cause injury to the 
muscle tendon unit, but the summative effect could be 
enormous. 
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Faulkner, Brooks, and Opitek (1993) suggested that 
injury from eccentric motion is attributable to the 
increased tension per individual cross bridge. Force 
development by a fiber during eccentric motion is 
approximately two times that developed during isometric 
movements, yet there is only a 10% increase in the number of 
cross bridges in eccentric motion (Faulkner et al., 1993). 
With a higher fiber to force ratio, mechanical disruption 
may occur to the ultrastructural elements in the muscle 
fibers such as the Z-line and contractile filaments and 
associated connective tissues (Armstrong, 1984). Duration 
and intensity of activity have also been shown to play an 
important role in fiber damage (Armstrong, 1984; Newham, 
1988). Although Tiidus and Ianazzo (1983) have suggested 
that intensity of activity has greater potency in causing 
muscle soreness than the duration of exercise, tendency for 
a negatively moving muscle fiber to be damaged is still 
great. 
Muscle types which have greater vulnerability to damage 
are: (a) two-joint muscles, (b) Type II fibers, and (c) 
muscles involved in eccentric motion (Garrett, 1990). His 
views are suggestive that activities which require burst, 
speed, and high tension recruit a greater percentage of Type 
II fibers and, due to the higher speed of contraction, the 
Type II muscles are likely to be predisposed to injury. As 
evidence, Friden (1984), had subjects perform eccentric 
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movement on a modified cycle ergometer. Micrographs from 
prepared tissues showed 4:1 ratio of Z-band anomalies for 
Type II to Type I fibers. Histological and ultrastructural 
analyses of muscle fibers indicate that whereas the Z-disk 
appears as a square lattice (Hoppeler, 1986), under damaged 
conditions the Z-disk shows streaming, broadening, and 
disruption in electron micrographs (Friden, 1984). 
Myofibrilla and sarcolemmal disruptions and widening of A 
band and I bands were also seen as signs of damaged muscle 
fibers (Armstrong, Ogilvie, & Schwane, 1983). 
Biochemical Damage 
The principal response involved in biochemical damage 
is inflammation at the site of the initial mechanical 
damage. Inflammation is in itself characterized by movement 
of fluid and migration of neutrophils and monocytes to the 
damaged area. Biochemical response help to promote 
clearance of damaged tissues, eliminate microbial invaders, 
and also promote tissue repair (MacIntyre, Darlene, & 
McKenzie 1995). Little is known as to when the injury 
process starts, but the inflammatory response is believed to 
follow the injury approximately between 3 and 4 after the 
damage (Armstrong, 1990). The associated pain sensation 
appears about 8 hours post-activity (Newham, 1988). 
Inflammation is associated with an initial 
vasoconstriction that lasts for 5-10 min followed by 
vasodilation, increased vascular permeability, and extrusion 
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of blood products into the surrounding tissues causing edema 
(Abramson & Weissmann, 1985). This is followed by 
recruitment of inflammatory cells such as leukocytes and 
macrophages which attract neutrophils to the injured site 
(Armstrong, 1990). Neutrophils have the ability to release 
agents that assist in the digestion of surrounding dead 
tissue cells. Since neutrophils have difficulty 
distinguishing between damaged and healthy tissues, healthy 
tissues may be mistaken for damaged or foreign bodies 
(Weiss, 1989). Under such circumstance, toxic agents are 
released by the neutrophils to attack healthy tissues, 
culminating in oxidative damage and further inflammation 
(Weiss, 1989). Neutrophils are also capable of causing 
tissue injury through the release of oxygen radicals. 
Oxygen radicals are highly reactive chemical species that 
have one or more unpaired electrons in the outer shell. In 
creating lipid peroxidation, free oxygen radicals decrease 
the barrier function of cell membranes. Free oxygen 
radicals are believed to be associated with necrosis and 
enzyme release following damaging exercise (Ebbeling & 
Clarkson, 1989). 
Prostaglandins, Mediator of Inflammation 
The origin of prostaglandins and the associated 
inflammatory symptoms including pain, redness, and swelling. 
Whereas some authors hypothesize prostaglandins as able to 
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sensitize pain endings to specific mediators (Brune, Menzel-
Soglowak, & Zeilhfer, 1992), others consider prostaglandins 
as modulators of inflammation (Willoughby & Sedgwick 1982). 
Onyanagui (1978) yet proposed that prostaglandins can 
potentiate the increased vascular permeability under the 
influence of other mediators namely, histamine, serotonin 
and kinin, which will likely cause edema. Prostaglandins 
are classified into stable such as PGE2 and PGF alpha and 
unstable example, PGEl (Wiessmann, 1982). PGEl is a 
vasodilator which, when injected into normal human skin, 
produces erythmia and pain. PGEl has also been shown to act 
with bradykinin and histamine to potentiate edema. The 
presence of prostaglandins in damaged muscles was observed 
in a study by Bansil, Wilson, and Stone (1986). After 
having 32 males perform squats, aspirin and placebo were 
administered. Blood drawn at preexercise and every 12 hours 
postexercise up to 72 hours was analyzed by 
radioimmunoassay. The results showed a significantly 
increased plasma levels of PGEl and PGF2 alpha in the 
placebo group. 
Prostaglandins and the Cyclcooxygenase Pathway 
The association between prostaglandins and the 
cyclooxenase pathway during inflammation is seen in the 
biotransformation of arachidonic acid in which 
cyclooxygenase plays a catalytic role. Arachidonic acid is 
a natural component of phospholipids in cell membrane and is 
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released from phospholipids in the presence of phagocytic 
cells (Weissmann, 1982). In the oxidation of arachidonic 
acid, cyclooxygenase and other enzymes act as catalysts to 
produce thromboxanes A2 and prostalandins. Thus, the extent 
of inflammation caused by mediating prostaglandins can be 
speculated to depend on the amount of cyclooxygenase 
available to catalyze the oxygenation of arachidonic acid. 
The same reaction produces an unstable endoperoxide, PGG 
which after oxidation produces hydroperoxy endoperoxide. In 
the end, free oxygen radicals are liberated to cause further 
damage (Allessio, 1993; Grisham & McCord, 1986; Jenkins & 
Goldfarb, 1993). 
The presence of tissue and cellular artifacts 
have variously been used as markers of tissue damage. After 
having subjects perform eccentric work, Clarkson, 
Litchfield, Graves, Kirwan, and Byrnes (1985) observed 
significantly greater muscular soreness and elevated muscle 
enzymes in the blood. Similar findings were made by 
Kuipers, Keizer, Verstappen, and Costill (1985) in a study 
in which three subjects performed an eccentric work bout for 
45 min and one for 60 min at 80% of the individual's maximal 
work load on a cycle ergometer. In all the 4 subjects used, 
moderate increases of muscle enzymes were observed. In 
addition, plasma concentration of creatine phosphokinase 
peaked at 24-hours postexercise. 
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Consequences of Muscle Fiber Damage 
Consequent to mechanical and biochemical damage to the 
muscle fiber, delayed-onset muscle soreness results along 
with a reduction in muscular force in the affected areas. 
Nonetheless, the time course of the two phenomena do not 
seem to be related. 
DOMS and Theories of Origin 
Opinions are divided on the chemical or physical agents 
that stimulate DOMS (Armstrong, 1984) which is felt 
approximately, 8 hours postexercise and peaking at 24 to 48 
hours after exercise (Abraham, 1977; Tiidus & Ianazzo, 
1983). DOMS is the aftermath of a strenuous activity and is 
characteristic of people who are not accustomed to such 
activities (Friden, 1984). Three causes of DOMS have been 
proposed namely, torn tissue (Hough, 1902), tonic spasm 
(deVries, 1966), and edema (Brendstrup, 1962). 
The Torn Tissue Theory 
From electromyographic (EMG) studies conducted by Hough 
(1902), muscle soreness observed in untrained individuals 
after heavy resistance work added to loss of contraction 
strength. Hough suggested the cause of the pain as due to 
rupture within the muscle itself or the connective tissue 
that transmits the pull of the fibers to the tendons. 
Tenderness is restricted to musculotendinous attachments, so 
that in the process of contraction, muscles pull on the 
injured tendons to cause pain (Newham, Mills, Quigley, & 
Edwards, 1983). The Torn Tissue model however, has not 
received substantial support over the years. 
Tonic Spasm Theory 
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deVries (1966) explained DOMS from an EMG point of 
view. The results of his investigations revealed a greater 
resting motor unit activity in sore muscles than in control 
subjects. He proposed the possibility that spasms within 
motor units can be the cause of DOMS. He also suggested 
that severity of the tonic activity is a factor of the 
number of motor units involved. A report by Cobb, deVries, 
Urban, and Leukens (1975) indicated that increases in EMG 
activity may be accompanied by muscle pain perception. 
Supporting this view, Bobbert et al. (1986) concluded that 
if tonic muscular spasm of motor units is present and is 
severe enough to partially occlude blood vessels, ischemia 
could result causing pain. Bobbert et al. (1986) had 11 
subjects perform plantar-dorsiflexion with one leg on a 20-
cm thick board while the other leg was held off the floor. 
Results of this study showed tonic spasm in some of the 
subjects. Even if all the subjects experienced pain or 
otherwise it is difficult to speculate if the discriminatory 
spasm is the actual cause of the pain. In a study conducted 
by Kami and Viitalaso (1977) however, pain was inferred as a 
probable cause for increased neural activation since more 
central activation, at a given tension, is required for sore 
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muscle compared to healthy ones. Komi and Viitalaso (1977) 
had four subjects perform concentric and eccentric exercises 
by exerting 40 maximal contractions, each lasting for 3.5 
sec with a 11.5 sec break. Knee angle was set at 107 
degrees and subject instructed to exert maximal force on an 
electromechanical dynamometer. EMG was recorded 
continuously before, during, immediately, and 2 days after 
the work. Muscle tension averaged for each contraction 
decreased substantially more in eccentric than in concentric 
fatigue conditions. An integrated EMG analysis showed that 
substantially more neural energy was needed for the 
production of certain muscle tension after fatigue loading 
than before. 
Edema and Intramuscular Pressure 
In a study conducted by Brendstrup (1962) using 
rabbits, an increase in water and chloride concentration 
were observed in the exercised muscles 24-48 hours after 
exercise but disappeared by 6 days. Since the time courses 
for postexercise pain and increased fluid content were 
similar, he attributed the pain to edema. Talag (1973) 
supported the edema model after observing increased limb 
volume at 24-, 48-, and 72-hours post-exercise which was 
accompanied with subsequent soreness. Fritz and Stauber 
(1988) used histological procedures to observe changes in 
the extracellular matrix of rat muscle 24 hours after 
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eccentric exercise. They suggested that disruption of 
proteoglycan components result in movement of water to the 
extracellular matrix through increased osmotic force. 
Diminished Muscle Performance and Causes 
There seems to be very little known about the duration 
of diminished muscle performance following muscle injury. 
Clarkson and Tremblay (1988) observed loss of performance up 
to 1-hour postexercise. Sergeant and Dolan (1987) had four 
subjects perform repeated eccentric contraction with leg 
extensor in a prolonged downhill (-25% grade) walking. 
Muscle function, expressed in terms of maximum voluntary 
contraction and short-term power output remained diminished 
for 96-hour postexercise. 
There is little in the literature on what causes loss 
in strength (MacIntyre, Darlene, & McKenzie, 1995). Studies 
have however speculated that the loss in muscle performance 
is attributed to biochemical and mechanical media namely, 
DOMS, edema, disorganized muscle morphology, or a 
combination. 
DOMS 
Several studies have supported the notion that the time 
of soreness sensation is occasioned with severely reduced 
muscle strength. The reasoning behind this is that during 
the periods of DOMS, victims feel very reluctant to 
voluntarily activate a muscle to move a limb. Newham et al. 
(1983) suggested that tenderness was restricted to 
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musculotendinous attachments, and as the muscle contracts, a 
pulling action is made on the injured tendons to cause pain. 
Because of the voluntary nature of movement, the existence 
of pain will offer victims little voluntary will to contract 
the sore muscles to generate maximal force. 
Muscle Morphology 
Muscle damage is associated with disorganization of the 
contractile material within the muscle fibers 
(Friden, 1984). The immediate loss of function may be due 
to overstretched sarcomeres. As a result, actin and myosin 
filaments are separated due to the high tension developed 
from the initial eccentric work which impairs force 
production. Faulkner et al. (1993) suggested that some 
sarcomeres stretch beyond a physiological limit during 
eccentric activity and become injured. Although there may 
be some metabolic involvement, Faulkner et al. (1993) 
believe that the initial decline in force may be a function 
of fatigue and mechanical injury which results in 
my-0fibrilla disruption at the Z-line level. 
Bi:Qchemical Factors (Calcium Extrusion and ATP Loss) 
Two substances considered to initiate biochemical 
damage are ATP and calcium. When actin and myosin are 
pulled apart, the sarcolemma is damaged allowing entry 
of extracellular calcium. Increased intracellular calcium 
in muscle cells from a damaged muscle sarcolemma or 
sarcoplasmic reticulum can induce biochemical damage to an 
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already mechanically damaged muscle fiber (Armstrong, 1984; 
Armstrong, 1990). A principal enzyme that has been 
identified as the underlining factor in the calcium pathway 
is phospholipase A2 (Duncan & Jackson, 1987). One action of 
phospholipase A2 is the breakdown of fatty acids and 
lysophospholipids in the sarcolemma (Armstrong, 1990). 
Fatty acids may in turn produce prostaglandins which will 
eventually mediate inflammatory reactions. 
Fiber Cross-sectional Area Model 
Friden (1984) explained the loss of contractile 
strength as due to the reduction in cross-sectional area of 
the injured muscle fiber. This is in accordance with the 
reasoning that a muscle fiber exert force directly 
proportional to its cross sectional area (Garrett, 1990). 
In a study by Mccully and Faulkner (1985), the left extensor 
digitorum longus of female albino mice were stimulated and 
performed isometric, shortening, or lengthening 
contractions. Similar muscles of the contralateral leg were 
used as a control. The results showed decrements in force 
at Day 3 in muscle which underwent lengthening contraction 
and also a strong correlation between loss in force and 
shrinkage in the total cross-sectional area. 
Physiological reactions in the body following 
biochemical and physical damage give rise to pain and 
reduced muscle performance. Whereas tonic spasm, edema and 
torn tissue have been speculated to mediate the pain, 
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diminished muscle performance is essentially believed to 
arise from pain, loss of calcium from the sarcolemma, 
overextended fiber length and emaciated fiber cross 
sectional area. 
Soreness Alleviating Procedures 
Athletes who sustain muscle injuries show several 
clinical signs including pain, swelling and such functional 
deficiencies as anatomical deformity, and athletic 
dysfunction (Kibler, 1990). He suggested that treatment of 
muscle injury must be geared towards reestablishing function 
rather than relief of symptoms. Traditional procedures of 
alleviating DOMS have constituted thermal therapy, 
cryotherapy, and physical therapy. In recent times, 
supplementary sources have been found in the form of 
pharmacological resources, predominantly non-steroidal anti-
inflammatory drugs (NSAIDs). NSAIDs are medicinal agents 
which are believed to inhibit the process of biochemical 
cellular degradation in soft tissues involved in 
inflammation. The mode of action of NSAIDs is thought to be 
inhibiting the synthesis and release of prostaglandins and 
inhibition of neutrophils (Abramson, Edelson, Kaplan, 
Ludewig, & Weissmann, 1984). Common examples of NSAIDs 
easily available for use currently are aspirin and 
ibuprofen. 
24 
Mechanism Of Action Of NSAIDs 
NSAIDs have been noted for their ability to act as an 
inhibitor to prostaglandins synthetase (Boots Lab leaflet, 
1994; Brune, 1982). In spite of the confusion regarding 
their pharmacology, researchers believe that NSAIDs act in 
the following three related ways. 
Analgesia 
The analgesic action of NSAIDs is observable from its 
ability to inhibit prostaglandin synthesis (McCormack & 
Brune, 1991; Brune et al., 1991). A study conducted by 
Brune et al. (1992) looked at changes in pain perception 
that result from tissue dam.age. The researchers suggested 
that tissue dam.age induced by prostaglandins can transform 
fine nerve endings of high threshold mechanoreceptor into a 
nociceptor. This transformation combines with increased 
reflex activity in the dorsal horn of the spinal cord to 
generate hyperalgesia associated with tissue dam.age. By 
inhibiting prostaglandin activities, NSAIDs reduce the 
nociceptive process. 
Anti-Nociception 
Braga, Biella, and Tiengo (1987) investigated the anti-
nociceptive action of aspirin and tenoxicam. on adjuvant-
induced arthritis in rats. They reported that intravenously 
administered aspirin (54 mg/kg) produced a marked anti-
nociceptive effect within 8 minutes. McCormick and 
Brune (1991) reported that NSAIDs possess antinociceptic 
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features which make them capable of shielding the injured 
site from pain sensation. This shielding mechanism could be 
critical in protecting pain nerve endings of the injured 
muscles. Presumably it serves as chemical blocks to 
excitations that could otherwise generate pain sensation in 
the affected sites. 
Anti-Inflammation 
The anti-inflammatory effect of aspirin and 
indomethacin may be attributed to its ability to inhibit the 
cyclooxygenase enzyme, a catalyst to the metabolism of 
arachidonic acid. By inhibiting the catalytic activities of 
cyclooxygenase, the biotransformation of arachidonic acid to 
thromboxanes and endoperoxides is prevented (Weissmann, 
1982). As a result, the production of endoperoxides and 
inflammation mediators are blocked (Onyanaugui, 1978). 
Since the quantity of thromboxanes, a mediator of 
inflammation is reduced, less inflammatory reaction is 
likely to occur. NSAIDs are also believed to inhibit oxygen 
radicals and are capable of scavenging OH-, thus 
transforming PGE2 (inflammatory) to PGH2 (less inflammatory) 
(Onyanaugui, 1978). 
In regressing inflammation, Almekinders (1993) 
recommended treatment to be aimed at initial symptoms of 
inflammation whereas subsequent treatment should be geared 
towards repair of the damaged muscle fibers. He further 
suggested the use of NSAIDs after injury but for a 
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relatively shorter period of time so as not to interfere 
with the subsequent muscle repair and remodeling process. 
This assertion was substantiated in a study by 
Almekinders and Gilbert, (1986) using three groups of 
Sprague-Dawley rats. Group 1 underwent muscle strain of the 
tibialis anterior muscle. They then rested in the post-
injury period. In Group 2 similar muscle was strained but 
piroxicam (10 mg/kg) was administered. Group 3 had no 
strain, immobilization, nor drug treatment. Histological 
evaluation showed hemorrhage and muscle fiber disruption 
along the strain. At Day 2, the group that underwent muscle 
strain showed extensive invasion of macrophages. There was 
but slight inflammation in the piroxicam treatment group 
with little monocytic response. Muscle tissues in the third 
group had normal microscopic appearance and also showed 
evidence of muscle regeneration. The delay in muscle 
regeneration of muscle fibers in the treatment group was 
attributed to the inhibition by piroxicam to inflammation. 
Ibuprofen has been studied on a limited scale in terms 
of its effect on DOMS. The few investigations conducted 
using ibuprofen and/or related NSAIDs have had conflicting 
conclusions regarding its efficacy in reducing DOMS and 
restoring muscle performance. 
27 
In a study by Donnell.y, Maughan, and Whiting (1990), 
ibuprofen did not reduce muscle soreness nor restore muscle 
strength after 32 subjects performed two bouts of downhill 
treadmill running separated by ten weeks. Group 1 (N = 16) 
received ibuprofen at first period and placebo at the 
second. Group 2 (N = 16) received placebo at first, but 
ibuprofen at the second period. Subjects ingested 600-mg 
ibuprofen or placebo 30 minutes before each exercise bout 
and took another 600 mg every 6 hours up to 72 hours post-
exercise for a total of 8,400 mg. Preexercise, 16-hr, 24-
hr, 48-hr, and 72-hr postexercise measures of muscle 
soreness indicated significant increases in total muscle 
soreness after each exercise bout. However, no difference 
in soreness response existed between the two treatments nor 
the first or second downhill run. Measurements of maximal 
voluntary force or isometric contraction of the legs 
decreased about 10% from initial leg strength. The group 
that received ibuprofen for the first bout and placebo for 
the second bout demonstrated the greatest decline in 
strength following exercise irrespective of treatment. 
Based on the results of this study, the researchers 
concluded that at a dosage of 600 mg/6 hour, ibuprofen is 
not effective in reducing DOMS nor muscle strength loss. 
They further suggested that DOMS may not be the result of 
inflammation. 
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In a similar study by Hasson et al. (1993), 
prophylactic or therapeutic use of ibuprofen were both found 
to be effective in reducing DOMS and improving muscle 
performance compared to placebo and control conditions. The 
20 subjects involved in this study were randomly assigned to 
a prophylactic group who ingested 400 mg of ibuprofen 4 
hours prior to the exercise or additional 800 mg over the 
next 24 hours; a therapeutic group which took 400 mg of 
ibuprofen at 24 hours postexercise and 800 mg over the 
following 24 hr; placebo group; and a control group. The 
exercise protocol involved step-ups on a bench that was 110% 
in height of the lower leg length while carrying an 
additional load that was 10% of subjects body weight. Pre-
exercise, 24-hr, and 48-hr postexercise muscular 
performance, creatine kinase and soreness perception were 
evaluated. The prophylactic ibuprofen group reported 
significantly less soreness than the therapeutic, placebo or 
control group. At 48-hr.postexercise, soreness was 
significantly less for prophylactic ibuprofen group than for 
the placebo and control groups. Maximal isometric 
contraction by an EMG as a percentage of change from 
baseline measures indicated that in all groups, maximum 
voluntary contraction was significantly reduced at 24 hours 
relative to baseline measures. The prophylactic group 
significantly decreased less in isometric force production 
than the therapeutic, placebo or control group. At 48 
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hours, maximum voluntary contraction declination from 
baseline value was significantly less than that of the 
placebo and control groups. They suggested that if the 
development of muscle soreness is an indication of 
inflammatory response, and a relationship exists between the 
magnitude of DOMS and inflammation, then the reduced 
soreness exhibited by the treatment groups will show 
markedly attenuate inflammation. 
Summary 
There is evidence in the literature which supports the 
view that DOMS arises from an initial mechanical damage. 
Following the trauma, biochemical reactions autogenic to the 
muscle fiber ensue. Evidently, eccentric motion is a 
plausible cause for the initial muscle injury. Later, the 
injury manifests itself in the form of inflammatory reaction 
and DOMS. An interplay of DOMS, disorganized muscle 
morphology, calcium loss, and ATP shortage then generate 
diminished muscle performance. Traditional and modern 
procedures ranging from cryotherapy, thermal therapy, 
physical therapy and pharmacological modalities have been 
prescribed to alleviate DOMS. Clinicians and physical 
therapists have resorted to and frequently prescribed the 
use of such pharmacological sources as aspirin, piroxicam, 
indomethacin and ibuprofen, generally referred to as NSAIDs. 
In spite of the popularity among users, ibuprofen does not 
seem to reduce DOMS or diminished muscle performance. 
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CHAPTER III 
METHODS 
The primary purpose of this study was to determine 
whether the oral ingestion of ibuprofen would cause a 
reduction in the sensation of muscle soreness that results 
from physical activity. The secondary purpose was to 
determine if ibuprofen can restore muscle performance more 
quickly than nontreatment group. A third purpose was to 
determine whether pre-exercise or post-exercise treatment of 
ibuprofen would generate differential effects on muscle 
soreness and degraded muscle performance. 
Subjects 
Twenty-nine male non-athletes from the University of 
Northern Iowa between the ages of 18 and 33 years 
volunteered to participate in this study. Eight subjects 
were unable to complete all phases of the study for various 
reasons, leaving 21 subjects that participated in the. 
research. The subjects were not engaged in any regular 
sports training requiring leg power nor had sustained any 
lower limb injury in 3 months prior to participation. 
All were fully informed of the nature and risk involved 
in the procedures to be used, and they provided informed 
consent. Subjects were instructed to abstain from exercise, 
ingesting alcohol, smoking, massage, using anti-inflammatory 
drugs, analgesics or thermal modalities during their 
involvement in the study. 
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Experimental Procedure 
All testing was conducted in the University of Northern 
Iowa's Human Performance Laboratory at the same times of day 
for each subject. Subjects reported to the laboratory three 
times throughout the study. On the first visit to the 
laboratory, each subject was randomly assigned to one of the 
following three groups: 
1. Control (Con): (n = 7)-no ibuprofen administered. 
2. Prophylactic ibuprofen (PI): (n = 7)-initial 600 mg 
ibuprofen taken 1 hr before exercise followed by 200 mg 
every 3-hr postexercise through 24-hr postexercise for a 
total of 2,200 mg of ibuprofen. 
3. Therapeutic ibuprofen, (TI): Cn = 12)-600 mg of 
ibuprofen at 24 hr and 200 mg every 3 hr up to 48 hr post-
exercise for a total of 2,200 mg. 
Baseline measures were made of each subject on the 
following dependent variables: perceived muscle soreness, 
anaerobic explosive power., fatigue index, maximal power, and 
work capacity. 
Soreness-Inducing Exercise Bout 
The exercise bout consisted of downhill running on the 
treadmill. All running was performed on either a Quinton 
Model 18-60 (Quinton Instruments, Seattle, Washington, USA) 
or Marquette 2000 T (SensorMedics Corporation, Yorba Linda, 
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California, USA) motorized treadmill. Heart rates were 
measured during exercise by telemetry using a Polar heart 
rate monitor (Polar CIC Inc. Fort Washington, NY, USA). 
The treadmill running begun with a 3-min warm-up. 
Subjects begun 1 min of walking. Afterwards, treadmill 
speed was increased progressively for subjects to start 
jogging for a 3-min warm-up. Treadmill speed was adjusted 
to attain a heart rate equivalent to 80% of estimated age 
adjusted (220-Age) maximal heart rate of subject. The 
treadmill was then declined to -10% for running for another 
30 minutes. Following the 30 minutes of downhill running, 
the treadmill speed was reduced to 2 k.hr-1 for a 2-min walk 
for recovery. 
Measurements 
Prior to the baseline measures, subjects received 
tutorials on the tests which were repeated at 0-hr 
24-hr, and 48-hr post-exercise in the order presented below. 
This order of presentation was adopted to avert the chances 
of fatigue from a more intensive activity influencing the 
results of subsequent tests. 
Muscular Soreness 
A visual analogue scale which had presumably been 
tested for reliability and validity, as used by Redenburg, 
Bar, and De Boer (1993), ranged from O (no soreness) to 6 
(intolerable soreness) was employed, see Appendix E. The 
scale was shown to subjects and explained as a self-
33 
reporting estimate of their soreness by picking the most 
appropriate adjective that describes muscle soreness on the 
scale. Soreness was measured in the following manner: from 
an erect position with hands held in front, the subject bent 
at the knees and hips until reaching 90 degrees at both the 
hip and knee joints. This position was held for 5 sec and 
repeated three times separated by a 10-sec rest. The 
subject then perceptually assessed their feelings of pain 
for all three trials and chose a number on the scale that 
was representative of the extent of his soreness. 
Vertical Jump 
Assessment of each subject's maximal reach was made 
initially. Standing 10 cm from and facing a wall, subjects 
rocked onto their toes and, with a powdered middle finger 
made a spot on the wall. The distance between the floor and 
the spot was measured and taken as subject's reach. 
Subjects then did five bound-offs and 1 min of stretching 
activities as warm-up. Subjects then dipped the tip of 
middle finger of dominant hand into powdered chalk. 
Standing perpendicular to and about 30 cm away from a wall, 
subjects lowered their body by bending at the hip and knee 
and jumped three times with 10 sec rest between jumps. This 
was performed maximally and placed a chalk mark on the wall 
at the apex of the jumps. Deviations of the height of the 
chalk spots from subjects' reach were measured and the mean 
value for the three repetitions was used. 
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Anaerobic Work Capacity 
Muscle work capacity was measured by using a 30-sec 
Wingate test (Patton & Duggan, 1983). A Monark 814 cycle 
ergometer (Ergomedics Sweden) with a weighted pan was used. 
A photocell (Sports Medicine Industries) interfaced with a 
personal computer was used to count flywheel revolutions. 
Before each test, the ergometer seat height was adjusted 
such that at the lowest pedal propulsion the legs are fully 
extended. Subjects' feet were slotted into stirrups of the 
pedal and warmed up on the cycle ergometer by gently 
pedalling for 3 min. Thereafter, subjects were instructed 
to increase pedalling rate steadily. On reaching maximal 
pedal rate within 5-10 sec, a weight equivalent to 7.5% of 
the subject's weight was applied. Subjects were verbally 
encouraged to maintain maximal effort during the 30-sec 
test. The weight was then removed while subjects pedalled 
at low resistance for 3 min to recover. 
Three variables were calculated by the computer: 
(a) maximal power-highest power output within any 5-sec 
period, (b) work output, and (c) rate of fatigue, the 
percentage of power drop off. To ensure compliance to the 
requirements of the study, subjects were directed to 
complete a general log which asked questions pertaining to 
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the timely ingestion of ibuprofen, abstention from smoking, 
alcohol, exercise and ingestion of extra NSAIDs. These 
forms were reviewed for any indicators which might exclude a 
given subject from the study. Subjects made second and 
third visits to the laboratory to go through all but the 
treadmill protocol at the same times with an interval of 
approximately 24 hours. 
Analysis of Data 
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A multivariate ANOVA with repeated measure on one 
factor was used to determine the effects of the treatment on 
muscle soreness and muscle performance and any interaction 
effect. Level of significance was established at .05. Data 
were entered into the mainframe computer at the University 
of Northern Iowa and were analyzed using the Statistical 
Package for the Social Sciences (SPSS). 
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CHAPTER IV 
RESULTS AND DISCUSSION 
The purpose of the study was to investigate whether 
ingestion of ibuprofen prior to or after a muscle-damaging 
exercise would reduce muscle soreness. A secondary purpose 
was to find out whether ingestion of ibuprofen would restore 
diminished muscle performance more quickly than without 
ibuprofen. The primary research hypothesis was that use of 
ibuprofen before or after the damage-inducing exercise would 
reduce muscle soreness and diminished muscle performance. 
Furthermore, prophylactic administration of ibuprofen was 
hypothesized to cause a greater reduction in soreness and 
diminished muscle performance. 
Results 
Twenty-one subjects completed all parts of the study. 
The mean age and weight of the subjects completing the study 
were 20.3 ± 1.7 yr and 77.4 ± 7.8 kg, respectively. 
Subjects' physical characteristics and raw data are 
presented in Appendix F. In Table 1 descriptive statistics 
of subjects at preexercise, 0-hr, 24-hr, and 48-hr 
postexercise of muscle soreness, fatigue, vertical jump, 
maximal power, and work capacity are presented. 
Table 1 
Descriptive Statistics of Soreness, Vertical Jump, Maximal 
Power, and Work Capacity (N = 21} 
Control Prophylactic Therapeutic 
Muscle Soreness (V/A Scale) 
PreEx 0.43 + 0.79 0.29 ± 0.49 0.14 ± 0.38 
0 hr 2.29 ± 0.76* 2.43 + 1.51* 2.15 .± 1.21* 
24 hr 3.00 
.± 1.41* 2.29 + 1.50* 3.29 ± 0.95* 
48 hr 3.43 ± 1.62* 2.14 ± 1.35* 2.71 + 1.38* 
Vertical Jump (cm) 
PreEx 43.33 ± 2.51 42.40 .± 3.73 45.90 .± 4.74 
0 hr 40.90 ± 2.26 40.15 + 3.72 42.40 ± 5.25 
24 hr 41.24 + 2.32 40.36 ± 3.68 40.06 + 4.90 
48 hr 41.40 + 2.21 41.07 
.± 3.91 41.46 + 4.03 
Fatigue Index (%) 
PreEx 27.09 + 12.00 24.13 
.± 9.50 27.67 ± 7.67 
0 hr 18.37 ± 10.36 24.54 + 18.89 31.57 ± 9.88 
24 hr 35.09 
.± 15.38 29.19 + 7.79 36.99 ± 7.50 
48 hr 26.66 ± 13.55 36.61 + 14.68 30.04 ± 5.66 
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{:table continued} 
Control 
Maximal Power (W) 
PreEx 908.14 ± 89.32 
0 hr 834.43 + 72.68 
24 hr 919.57 + 111.75 
48 hr 920.43 + 97.70 
Work Capacity (kJ) 
PreEx 23.57 + 17.53 
0 hr 22.84 ± 18.30 
24 hr 23.43 ± 34.39 
48 hr 24.34 + 24.45 
Prophylactic 
813.43 + 53.23 
833.71 ± 62.22 
882.00 ± 68.75 
815.29 ± 103.97 
21.56 + 16.44 
22.55 ± 18.73 
22.62 ± 17.34 
20.59 + 28.73 
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Therapeutic 
857.86 ± 120.28 
844.14 ± 161.88 
873.43 ± 162.19 
894.71 + 180.75 
22.53 ± 36.62 
20.37 ± 21.64 
21.57 ± 47.64 
22.86 ± 52.09 
Note. There were no significant main or time effects 
between the treatment and control groups (R > .05). 
*=Significantly different from preexercise values 
(R < .05). 
PreEx = Preexercise. 
Muscle Soreness 
In all groups, muscle soreness significantly increased 
after the exercise protocol for all postexercise periods 
compared to preexercise values. However, there were no 
significant differences at any of the preexercise and 
postexercise measuring times between treatment and control 
groups. 
Fatigue Index 
Preexercise and postexercise changes in fatigue index 
did not show any significant differences between treatment 
and control groups. 
Vertical Jump 
At all measuring times, vertical jump values between 
treatment and control groups were not significantly 
different. 
Maximal Power 
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At preexercise and all postexercise measuring times, 
there were no significant differences between treatment and 
control groups. 
Work Capacity 
Postexercise changes in work capacity from baseline 
values were highly variable. Work capacity at Ohr and 
24-hr postexercise, relative to preexercise, decreased in 
the control and therapeutic groups. In the prophylactic 
group however, work capacity increased above preexercise 
value. At 48-hr postexercise, a reverse of the situation 
was observed. In spite of these inconsistencies and 
variabilities, there were no significant differences in work 
capacity of the treatment and control groups at all 
measuring times. 
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Discussion 
The present study was designed to measure two 
conditions of ibuprofen administration to test its 
effectiveness in reducing muscle soreness and restoration of 
diminished muscle performance following a damage-inducing 
exercise. A 2,200-mg prophylactic administration of 
ibuprofen ingested over 24 hr was intended to ensure peak 
plasma level of ibuprofen before exercise (Pyne, 1994). The 
therapeutic administration was given 24-hr postexercise and 
was hypothesized to prevent further damage from occurring. 
The present study failed to demonstrate the 
effectiveness of ibuprofen in reducing muscle soreness and 
diminished muscle performance. The findings are in 
agreement with the conclusions of other studies. Donnelly 
Maughan, and Whiting (1990) found ibuprofen ineffective in 
the treatment of DOMS or muscle strength loss at a total 
dosage of 8,400 mg over 24 hr. Also, Kuipers et al. (1985) 
concluded that flurbiprofen, an ibuprofen-related drug, was 
ineffective in the treatment of DOMS. The lack of treatment 
effect by ibuprofen could be attributed to a combination of 
at least two factors. 
First, Gracely and Kwilosz (1988) have suggested that 
subjectjve assessment of pain is associated with a flaw 
termed as scaling error. From their view, repetitive use of 
the same soreness scale has the potential to provide 
subjects with the same category or part of a line or to 
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remember past specific response. They did not, however, 
indicate any likelihood of differences in pain measurement 
due to the flaw. They further argue that since pain 
sensation has both sensory and physiologic components, a 
more versatile instrument should be designed to measure 
DOMS. Contrary to expectations, all three groups in this 
study had some level of soreness at preexercise time. This 
likely implies that some bodily discomfort other than 
soreness was being measured. 
Second, the period of soreness evaluation may not have 
been long enough for any distinct intergroup differences to 
be observed in subjects in the postexercise period. It is 
possible that, beyond 48-hr postexercise, the rate of muscle 
soreness decrease in the treatment group could be faster 
than in the control group. Even though the prophylactic 
group ingested an initial 600 mg of ibuprofen 1 hour prior 
to the treadmill run, no marked effect was observed on 
muscle soreness and muscle performance. 
Whereas dosage has a potential influence on the level 
of muscle soreness in human subjects, McCormack and Brune 
(1991) suggested that when administering NSAIDs, the target 
pain must be intense enough to significantly distinguish 
perceived soreness of the treatment group from placebo 
group. To date, studies which tested ibuprofen for its 
effectiveness in regressing DOMS are inconclusive in their 
findings. At 500 mg, diclofenac, an ibuprofen-related 
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NSAID, was effective in reducing soreness at specific spots 
in humans (Donnelly, McCormick, Maughan, Whiting, & 
Clarkson, 1988). Hasson et al. (1993) administered a total 
of 1,200 mg/day of ibuprofen in a study and found it 
effective in reducing both muscle soreness and diminished 
muscle performance. 
Additional factors that could possibly cause lack of 
treatment effect are the exercise protocol employed, 
duration of exercise bout and dosage/duration interaction of 
drug administration. As evidence, Hasson et al. (1993) 
found ibuprofen effective in reducing both muscle soreness 
and diminished muscle performance. Subjects performed step-
ups in which lowering the body was done on one leg to induce 
muscle soreness. Because this movement is not as common in 
human motion as running exercise, it may have caused greater 
damage than from the 30-min downhill running utilized in the 
present study. This was supported from the lack of 
difference between preexercise and postexercise values of 
the fatigue index and work capacity. 
Exercise duration poses a critical factor in 
determining extent of damage. Kuipers et al. (1985) had 
subjects perform eccentric cycling for 30 min at 80% of 
maximal oxygen uptake. Later, subjects performed the same 
activity for 45 and 60 min. In subjects who performed for 
30 min, histological examination did not show any 
inflammation. Subjects in the 45-min and 60-min exercise 
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bouts groups however, showed inflammation. Similarly, 
Schwane and Armstrong (1983) noticed pronounced enzyme 
release, a marker of sarcolemma damage, in subjects who 
performed downhill running for 45 min but not after 30 min. 
Since the present protocol lasted only 30 min, it is 
possible that the duration and/or intensity were not enough 
to induce sufficient tissue damage. 
Dosage/duration interaction of drug administration 
seems a more reasonable factor to consider in attempting to 
establish lack of treatment effect of a drug. Considering 
dosage or duration of treatment alone there is seemingly 
little certainty about what impact each factor could exert 
on DOMS and diminished muscle performance. It is therefore 
reasonable to concede that a more versatile factor would be 
a combination of the two. Credence to this view is given in 
a study by McLatchie et al. (1985). The study was designed 
to justify the benefits for the use of NSAIDs in injuries 
which when left untreated would eventually heal. In the 3-
day study, 144 sport persons who had sustained Grade 1 (mild 
stretching of the ankle ligament with no instability) or 
Grade 2 injury (moderate sprain with incomplete tear and 
mild instability) were randomly assigned to ibuprofen 
groups, 600 mg/4 daily; 1200 mg/2 daily and placebo 
ibuprofen group. Subjects were assessed at Day 1, Day 3, 
and Day 7 for joint tenderness, muscle movement, overall 
severity, and match fitness. Even though the results 
indicated significant treatment effect in both active 
treatment groups, the 4 times daily group was superior. 
Relating to the findings, this suggest that the dosage 
utilized in the current study was insufficient to reduce 
soreness. 
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Results from the vertical jump, fatigue index, maximal 
power, and work capacity tests fluctuated considerably from 
preexercise values. This is very misleading, yet, does not 
conceal probable reasons underlying the lack of treatment 
effect on performance. In the present study, vertical jump 
in the respective groups declined from preexercise values at 
all postexercise times which implies that the exercise bout 
had affected performance. Supportive of this, two subjects 
randomly chosen had increased thigh circumferences at 24-hr 
postexercise. The fatigue indexes for the control group at 
0-hr and 48-hr postexercise were not significantly lower 
than preexercise levels. 
An interesting phenomenon that this study did not 
observe is a second loss in force in mice as reported by 
Faulkner et al. (1993). They reported that the second loss 
of force in the postexercise period might be related to 
DOMS. Faulkner et al. (1993) believed that the initial loss 
in force could be a factor of mechanical injury and fatigue. 
They also suggested that a second biochemical injury occurs 
to the muscle as a result of the phagocytic activity at the 
site of original damage possibly causing deterioration in 
the muscle fiber resulting in loss of force. 
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Perhaps the most surprising findings of this study is a 
seemingly lack of relationship between the fatigue index and 
maximal power. In all groups, fatigue index was greater at 
all postexercise times except for the control group at 0-hr 
and 48-hr. However, the postexercise increases of the 
fatigue index did not correspond to the postexercise 
decrements in maximal power. The correlation coefficients 
for fatigue and maximal power for the four measuring times 
were as follows: preexercise (£ = .291), 0 hr(£= .959), 24 
hr (r = .248), and 48 hr(£= .138). 
If the exercise protocol in the present study did not 
cause sufficient damage, then a possible speculation that 
can be made is that damage which results in ultrastructural 
disorganization in fiber may be a more potent factor in 
determining muscle function. The speculation is based on 
the assumption that the intensity and duration of the 
exercise protocol were not enough to cause sufficient damage 
to the muscle fibers even though some level of soreness was 
experienced, postexercise levels of muscle performance 
remained higher. It is possible that if the exercise 
protocol had caused maximal structural damage to the 
mus~les, force production could have been impaired. In 
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summary, the findings of this study failed to support the 
capability of ibuprofen in reducing muscle soreness and 
diminished muscle performance at a dosage of 2,200 mg/24 hr. 
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CHAPTER V 
CONCLUSIONS, IMPLICATIONS, AND RECOMMENDATIONS 
FOR FURTHER STUDIES 
The purpose of this study was to investigate whether 
the ingestion of ibuprofen before and after a muscle-
damaging activity would reduce exercise-induced muscle 
soreness. A second purpose was to investigate whether the 
ibuprofen would greatly cause decrements in diminished 
muscle performance. Thirdly, the study investigated which 
of the two modes of drug administration, prophylactic and 
therapeutic, is superior in reducing soreness and diminished 
muscle performance. 
Conclusions 
Based on the results of this study, the researcher 
concluded that: 
1. Ibuprofen at a total dosage of 2,200 mg/day does 
not diminish DOMS up to 48-hr postexercise. 
2. Ibuprofen does not help·restore muscle performance 
more quickly in treatment group than in control group 
following a 30-min downhill (-10% grade) treadmill run. 
3. Prophylactic treatment was not superior to either 
therapeutic or control in reducing DOMS and restoring muscle 
performance. 
Implications 
From the results of this study, it could be suggested 
that the use of ibuprofen, a common practice among athletes 
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may not, after all, be beneficial for purpose of reducing 
DOMS and restoring muscle performance. 
Recommendations for Further Study 
Based on the results of this study, the following 
recommendations for repeated studies are made: 
1. The use of a larger sample size so as to attain a 
threshold point where group differences in treatment if any, 
would be distinct. 
2. The employment of a more standardized and objective 
soreness measuring instrument in assessing muscle soreness. 
3. Use of an additional questionnaire that would 
incorporate both the affective and sensory components to 
pain (Gracely & Kwilosz, 1988). 
4. Use of homogeneous subjects. Test for similarities 
in physical characteristics in terms of age of age, sex 
athletic level and skill should be conducted prior to 
participation (Bar-Or, 1987). 
5. Increased dosage and longer period of ibuprofen 
administration. 
6. Extension of postexercise period of testing and 
data collection must be made to ensure that a point is 
reached where group difference in response to treatment 
become distinct. 
7. Employment of a more intense and longer duration 
exercise is recommended. 
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8. Assessment of muscle performance should be done 
side-by-side with muscle biopsy in order to measure changes 
in performance against any possible morphological 
irregularities and changes in blood variables like creatine 
kinase. In this way, questionable trends in performance and 
soreness can be matched against possible instrumental and 
sampling errors. 
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SUBJECTS IN~ORMED CONSENT 
I hereby consent to take part in a research directed by 
Atta Kofi Osei, School of Physical Education and Leisure 
Services, University of Northern Iowa. I understand that 
other persons may assist this individual or be associated 
with him. 
I understand that: 
1. This research is to investigate the effect 
ibuprofen may have on exercise-induced muscle pain. 
2. This will be my part in the research: to have 
soreness perception, muscle power and muscle capacity 
assessed daily for three days; complete a 30-minute running 
on a treadmill declined to -10%, on the first visit; orally 
ingest the required dosage of ibuprofen as stipulated by the 
study; stay away from massaging or ingestion of additional 
dosage of pain killers. These procedures would be conducted 
in the Human Performance Laboratory, 207 West Gymnasium, 
UNI. 
3. Participation in the research will require 
approximately a total 3 hours of my time. 
4. My participation is voluntary. I am free to stop 
participating at any time. If I do not volunteer or if my 
participation is ended for any reason by the researcher or 
me, this will involve no penalty or loss of any of the 
benefits to which I am entitled. 
59 
5. I will be told of any significant new information 
that might affect my willingness to take part in this 
research. 
6. These benefits can be expected from the research: 
I will receive useful information about my age adjusted 
(220-Age) maximum heart rate; muscle power and anaerobic 
capacity, extent to which my sore muscle could sustain 
itself under resistance, rate of my body's response to 
NSAIDs and extent of treadmill running at -10% declination. 
7. My participation will expose me to the following 
risks: Leg instability to moderate intensity exercise for 
30 minutes can cause leg fatigue and general tiredness. 
Dizziness and loss of consciousness, although rare, are 
likely results of explosive cycle ergometer pedalling. 
Standard safety procedures will be used, and qualified 
personnel will be present for assistance during exercise 
testing. 
8. There are no other satisfactory procedures to 
obtain information needed for this research. 
9. The following steps will be taken to protect the 
confidentiality of my identity and the data I have 
contributed: All data will be filed in locked rooms. Only 
averages will be reported and the data will not be linked 
with any individual in published or oral reports. The 
investigator will keep an identifier key, but the subjects 
may request the identity link to his data to be destroyed. 
Otherwise, the data will be maintained in storage for an 
indefinite period. 
10. I will receive no monetary or other compensation 
for my time. 
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11. I further allow Atta K. Osei and his assistants or 
associates to perform the procedures referred to above, 
report their findings to government agencies, funding 
agencies, manufacturers, or scientific bodies, and to 
publish their findings. My questions about this research 
have been answered. If I do have any further questions, I 
am to contact Atta K. Osei at the school office in West 
Gymnasium, 273-2141 or 277-4629, 2113 Main Street, Cedar 
Falls, IA 50613 or Dr. Fred Kolkhorst, 207B West Gymnasium, 
273- 5921. Questions regarding this research project and 
the rights of research subjects also may be directed to the 
Human Subjects Coordinator, University of Northern Iowa, 
273-2748. I am fully aware of the nature and extent of my 
participation in this project as stated above and the 
possible risks involved. I hereby agree to participate in 
this project. I acknowledge receipt of a copy of this 
consent statement. 
Signature of Volunteer Date 
Printed Name of Volunteer 
APPENDIX B 
SUBJECTS NOTATION SHEET 
61 
SUBJECTS NOTATION SHEET 
NAME: 
CODE: 
NOTE IF YOU DID ANY OF THE FOLLOWING: 
1. Did you involve in any vigorous physical activity? 
Yes No 
If yes, what type and how long? 
2. Did you take additional pain killers or any drug to 
suppress pain within the study period? Yes No 
If yes, please indicate the type of medication dosage, and 
day 
1 (testing day) 
2 (recovery day 1) 
3 (recovery day 2) 
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SUBJECTS PRETEST QUESTIONNAIRE 
NAME: 
CODE: 
(Circle one) 
1. Do you have any known heart diseases? Yes No 
2. Do you have asthma? Yes No 
3. Do you have any physiological/physical impairment that 
will make it difficult to: 
*run on the treadmill? 
*pedal the ergometer? 
*jump the wall? 
If yes, describe: 
Yes 
Yes 
Yes 
No 
No 
No 
4. Are you currently taking medications? Yes No 
If yes, please list all medications and why you are 
taking them. 
S. Please describe any regular physical activity you are 
involved in. 
*jogging (mileage) 
*sport (name) duration and number of times per week. 
*aerobic exercises/dancing; duration and number of 
times per week. 
6. Have you ever taken any pain killers? 
advil, tylenol, anacin, aspirin). 
If yes, when was the last time? 
What dosage? 
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(i.e. ibuprofen, 
Yes No 
How often do/did you take the said drug? 
2*2 daily 1*2 daily 2*1 daily other (explain) 
7 . Have you ever taken any -sllbstance in order to regress 
pain in physical performance? Yes No 
If yes, please explain. 
APPENDIX D 
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SUBJECTS PERSONAL DATA SHEET 
Name: Code#: _____ _ 
Age: Weight: __ _ Reach: 
------
Soreness Vet. Jump Fatigue Max. Power Work Output 
PreEx 
0 hr 
24 hrs 
48 hrs 
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VISUAL ANALOGUE SCALE 
Numerical Rating 
0 
1 
2 
3 
4 
5 
6 
Description of Feelings 
No Soreness 
Dull feeling of soreness 
Light continuous soreness 
More than light soreness 
Annoying soreness 
Severe soreness 
Intolerable soreness 
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Grp Age Wgt 
(Kg) 
Subj 1 1 20 85 
2 1 20 81 
3 1 20 77 
4 2 22 76 
5 3 19 74 
6 3 19 86 
7 3 22 81 
8 2 24 78 
9 1 19 77 
10 1 19 69 
11 2 22 76 
12 2 18 74 
13 3 18 75 
14 3 21 85 
15 1 21 98 
16 1 22 81 
17 2 20 67 
18 2 22 62 
19 3 19 68 
20 3 20 80 
21 2 18 74 
Snss = Soreness 
A'bic = Aerobic 
An'bic = Anaerobic 
Grp = Group 
Wgt = Weight 
Ftg = Fatigue 
Pwr = Power 
Jmp = Jump 
Vert= Vertical 
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RAW DATA 
PRE-EXERCISE 
Snss A'bic Power An'bic Wrk Capacity 
Vert. Jmp Ftg Max.Pwr Work 
(Inch) (%) (W) (Kj) 
0 13 31 922 25152 
0 18 26 937 24937 
2 17 45 936 21270 
1 13 31 867 22723 
0 14 16 1050 29572 
0 22 30 978 24775 
0 25 30 863 22372 
0 14 34 845 20540 
0 15 19 815 22225 
0 21 10 768 21666 
0 13 21 791 20926 
0 17 20 751 20248 
0 21 23 720 20030 
1 12 29 776 19769 
0 17 38 1037 24684 
1 18 20 942 25024 
0 22 34 767 19551 
1 16 07 784 22992 
0 16 26 820 22101 
0 19 41 789 19104 
0 21 22 889 23929 
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RAW DATA 
IMMEDIATE POST-EXERCISE 
Snss. A'bic Power Anaerobic Work Capacity 
Vert. Jmp Ftg Mx. Power Work 
(Inch) (%) (W) (Kj) 
Subj 1 2 13 34 875 23067 
2 3 17 15 780 21468 
3 3 17 26 806 21128 
4 4 13 26 885 23719 
5 2 13 26 1167 21157 
6 4 22 13 853 23825 
7 1 23 32 895 21666 
8 1 14 18 788 21800 
9 2 16 08 750 22201 
10 1 20 24 880 22227 
11 2 11 20 826 22812 
12 4 16 13 742 21038 
13 3 20 42 839 20681 
14 3 11 39 675 17597 
15 2 15 18 958 26631 
16 3 15 05 792 23127 
17 4 21 66 840 19779 
18 2 16 15 933 25497 
19 1 11 37 741 19683 
20 1 18 32 739 18003 
21 1 20 13 822 23179 
73 
RAW DATA 
24-HOUR POST EXERCISE 
Snss A,bic Power Anaerobic Work Capacity 
Vet. Jump Ftg Power Work 
(inch) (%) (W) ( Kj) 
Subj 1 4 13 28 943 25266 
2 4 15 13 907 25534 
3 5 16 45 954 21522 
4 3 13 37 985 24175 
5 2 12 31 1197 30783 
6 4 21 34 929 23719 
7 2 23 29 676 16593 
8 2 14 35 793 19689 
9 1 17 31 945 23807 
10 2 20 41 946 24405 
11 0 12 19 794 21671 
12 5 16 27 885 22662 
13 4 19 37 869 21905 
14 4 12 34 815 20701 
15 2 18 61 688 16594 
16 3 15 27 1054 26853 
17 2 21 37 910 22466 
18 2 16 19 890 25407 
19 4 12 43 831 20541 
20 3 18 51 797 17226 
21 2 20 31 917 23283 
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RAW DATA 
48-HOUR POS-EXERCISE 
Snss A,bic Power Anaerobic Work Capacity 
Vet Jump Ftg Power Work 
(inch) (%) (W) ( Kj) 
Subj 1 3 13 10 875 24973 
2 3 15 07 898 26060 
3 6 16 41 955 22521 
4 3 14 34 987 24479 
5 2 11 28 1213 31850 
6 3 21 25 943 24702 
7 1 23 30 945 23800 
8 2 14 26 861 22412 
9 3 16 26 893 23340 
10 3 20 36 943 24270 
11 0 12 20 749 20365 
12 4 15 28 874 22606 
13 1 20 32 935 23876 
14 4 10 22 810 21775 
15 1 18 39 779 20852 
16 5 17 28 1100 28342 
17 3 22 36 830 20319 
18 1 16 62 705 16452 
19 4 10 37 632 15163 
20 4 20 37 785 18824 
21 2 21 50 701 17464 
